Adult Services, Oncology/Hematology

Mia Jusufbegovic, M.D., joins Norton Cancer Institute

Mia Jusufbegovic, M.D., has joined Norton Cancer Institute as its first head and neck oncology and microvascular reconstructive surgeon treating complex ear, nose and throat oncology cases. Dr. Jusufbegovic earned her medical degree from the University of Louisville School of Medicine, where she also completed her residency training in otolaryngology and head and neck surgery….

Read Full Story
Neuro-Oncology, Oncology/Hematology, Pediatric Services

Pediatricians’ primer on childhood CNS tumors

Tumors in the central nervous system (CNS) account for 20% of childhood cancers, with 5.65 cases and 0.72 deaths per 100,000 children under 14 in the United States. Brain tumors are second only to acute lymphoblastic leukemia in incidence. While recent advances have resulted in greater life expectancy for some childhood CNS tumor patients, the…

Read Full Story
Oncology/Hematology, Pediatric Services

MEK Inhibitor shrinks large hypothalamic enhancing tumor in teen

The patient A 14-year-old female presented with worsening headache and deterioration of vision especially in the left eye. MRI detected a large hypothalamic enhancing tumor causing mass effect on the optic nerves. The pituitary gland appeared to be pushed inferiorly. The challenge Because of tumor location and potential complications with tumor resection, the multidisciplinary team…

Read Full Story
Neuro-Oncology, Oncology/Hematology, Pediatric Services

Classification and treatment of pediatric cancerous brain tumor, medulloblastoma

Medulloblastoma is one of the most common malignant brain tumors in children, with cases tending to surface around ages 4 or 5. Currently, the treatment protocol is resection of as much of the tumor as can be done safely, followed by concurrent radiation therapy and chemotherapy, according to Mustafa Barbour, M.D., pediatric hematologist/oncologist at Norton…

Read Full Story
Neuro-Oncology, Oncology/Hematology, Pediatric Services

Diagnosing and treating brain tumors in children

There are many types and subtypes of brain tumors in children, and heterogeneity is common among tumors with similar morphology, according to Mustafa Barbour, M.D., pediatric hematologist/oncologist at Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine. Dr. Barbour is co-director of the Norton Children’s Cancer Institute Neuro-oncology Clinic. Many brain tumors in…

Read Full Story
Adult Services, Oncology/Hematology

Douglas A. Nelson, M.D., joins Norton Cancer Institute

Douglas A. Nelson, M.D., has joined Norton Cancer Institute, practicing at the downtown Louisville and St. Matthews offices. Dr. Nelson most recently was an associate professor in the Department of Gastrointestinal Medical Oncology and Department of General Oncology at the University of Texas MD Anderson Cancer Center – The Woodlands, in Conroe. Dr. Nelson served as…

Read Full Story
Adult Services, Oncology/Hematology, Research

Clinical trial summary: Venetoclax plus LDAC for adult AML patients at high risk of toxicity

Clinical challenge Acute myeloid leukemia (AML) patients ages 75 and older, and younger adults with comorbidities, are often ineligible to receive standard intensive chemotherapy due to high rates of toxicity and early mortality. As a result, supportive care is all that’s available to about 60% of adults 75 or older and younger adults with comorbidities….

Read Full Story
Adult Services, Oncology/Hematology

Cancer care for the whole person includes emotional health

No one needs to face cancer alone. A cancer diagnosis is life-altering, and living with cancer can cause feelings of fear, sadness, nervousness and uncertainty, and a sense of being overwhelmed. At Norton Cancer Institute, the health care team understands that patients need both leading-edge medical care and support for their mental and emotional health…

Read Full Story
Oncology/Hematology, Pediatric Services, Weight Management

The acute lymphoblastic leukemia link to obesity

Survivors of the most common childhood cancer, acute lymphoblastic leukemia (ALL), need long-term monitoring for obesity and other ongoing health consequences of their disease and treatment. “The etiology of obesity among ALL survivors is not fully understood, but the primary tumor, hypothalamic-pituitary axis damage from cranial radiation or chemotherapy, lifestyle modifications, and genetics all may…

Read Full Story
Oncology/Hematology, Pediatric Services

Burkitt lymphoma, one of the more common forms of non-Hodgkin lymphoma, has a variety of clinical presentations

Burkitt lymphoma, an aggressive subtype of non-Hodgkin lymphoma (NHL), accounts for 40% of all NHL cases in the United States. This high-grade, fast-growing form of lymphoma starts in the immune system’s B cells and has a doubling time of 24 to 48 hours. It affects children of all ages, but it is most common in…

Read Full Story
Oncology/Hematology, Pediatric Services

Immunotherapy for refractory B-cell acute lymphoblastic leukemia

The five-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has reached about 90% with chemotherapy. Clinicians increasingly are turning to immunotherapy for relapsed/refractory B-cell ALL (B-ALL). Immunotherapy harnesses the innate power of the body’s own immune system to destroy cancer cells. “It may be early to know definitively the full implications…

Read Full Story
Oncology/Hematology, Pediatric Services

Don’t overlook these signs and symptoms of leukemia in children

Pediatricians can help with early detection of childhood leukemia during routine visits. Even though a patient’s signs and symptoms may appear vague, mild or suggestive of more common health conditions, they shouldn’t be ignored. In some cases, doctors reported that ordering a simple blood test led to a cancer diagnosis that otherwise could have remained…

Read Full Story